150
Participants
Start Date
February 28, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
July 31, 2015
ABT-436
Target dose - 400mg BID
Matched Placebo - Sugar Pill
Target Dose - 2 pills BID
University of Pennsylvania, Philadelphia
Johns Hopkins University School of Medicine, Baltimore
University of Virginia, Charlottesville
Boston Medical Center, Boston
Boston Medical Center, Quincy
Collaborators (1)
AbbVie
INDUSTRY
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH